Letters in Drug Design & Discovery

G. Perry
University of Texas
San Antonio, TX
USA
Email: lddd@benthamscience.org

Back

Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 Inhibitors

Author(s): Stefano Moro, Flavia Varano, Giorgio Cozza, Mario A. Pagano, Giuseppe Zagotto, Adriana Chilin, Adriano Guiotto, Daniela Catarzi, Vittoria Calotta, Lorenzo A. Pinna.

Abstract:

Casein kinase 2 (CK2) is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and infective diseases. Using a combined virtual screening approach, we have identified the pyrazoloquinazoline tricyclic system as a novel scaffold to design new kinase CK2 inhibitors.

Keywords: Kinase CK2, CK2 inhibitors, virtual screening

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 3
ISSUE: 4
Year: 2006
Page: [281 - 284]
Pages: 4
DOI: 10.2174/157018006776743233
Price: $58